Technology, Risks and Benefits
How do we treat Keratoconus?
NQ Eye Specialists now offer Corneal Collagen Cross-linking (CXL). This procedure is used to slow down or halt the progression of Keratoconus.
What technology is used in the treatment of Keratoconus?
The CXL procedure is performed under a topical anaesthetic. Firstly, the outer layer of the cornea is removed. After this, Vitamin B2 drops are applied to the Cornea and the Cornea is then exposed to Ultra Violet light. This process causes a chemical reaction, resulting in an increased number of bonds between collagen fibres resulting in a strengthened Cornea.
What are the risks of Keratoconus treatment, if any?
The CXL procedure can cause some inflammation this will usually resolve with the use of eye drops. There is also a risk that the procedure will not prevent further progression of Keratoconus.
What are the benefits of Keratoconus treatment?
The aim of CXL is to halt progression of the disease and prevent your vision from getting worse. It usually does not improve vision or reduce the need for glasses or contact lenses.